Ginsenoside Rg3 targets glycosylation of PD-L1 to enhance anti-tumor immunity in non-small cell lung cancer.
Wang W, Kong M, Shen F, Li P, Chen C, Li Y, Li C, Qian Z, Zhong A, Wang Y, Yang L, He F, Li W.
Wang W, et al. Among authors: li c, li y, li w, li p.
Front Immunol. 2024 Aug 23;15:1434078. doi: 10.3389/fimmu.2024.1434078. eCollection 2024.
Front Immunol. 2024.
PMID: 39247194
Free PMC article.